Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity.

Morsy H, Taha EA, Nigm DA, Shahin R, Youssef EMK.

Clin Exp Dermatol. 2017 Dec;42(8):868-873. doi: 10.1111/ced.13213. Epub 2017 Sep 20.

PMID:
28940568
2.

Reliability, Validity, and Sensitivity to Change Overtime of the Modified Melasma Area and Severity Index Score.

Abou-Taleb DA, Ibrahim AK, Youssef EM, Moubasher AE.

Dermatol Surg. 2017 Feb;43(2):210-217. doi: 10.1097/DSS.0000000000000974.

PMID:
27930379
3.

The life cycle of Hexangium sigani Goto & Ozaki, 1929 (Digenea: Microscaphidiidae) from the Red Sea.

Hassanine RM, Al-Zahrani DA, Touliabah Hel-S, Youssef EM.

J Helminthol. 2016 Sep;90(5):539-46. doi: 10.1017/S0022149X1500070X. Epub 2015 Aug 17.

PMID:
26279005
4.

Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.

Moubasher AE, Youssef EM, Abou-Taleb DA.

Dermatol Surg. 2014 Aug;40(8):874-82. doi: 10.1097/DSS.0000000000000065.

PMID:
25068546
5.

Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease.

Baker AR, Harte AL, Howell N, Pritlove DC, Ranasinghe AM, da Silva NF, Youssef EM, Khunti K, Davies MJ, Bonser RS, Kumar S, Pagano D, McTernan PG.

J Clin Endocrinol Metab. 2009 Jan;94(1):261-7. doi: 10.1210/jc.2007-2579. Epub 2008 Nov 4.

PMID:
18984670
6.

Effect of cytarabine and decitabine in combination in human leukemic cell lines.

Qin T, Youssef EM, Jelinek J, Chen R, Yang AS, Garcia-Manero G, Issa JP.

Clin Cancer Res. 2007 Jul 15;13(14):4225-32.

7.

Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer.

Montero AJ, Díaz-Montero CM, Mao L, Youssef EM, Estecio M, Shen L, Issa JP.

Cancer Biol Ther. 2006 Nov;5(11):1494-501. Epub 2006 Nov 19.

PMID:
17369752
8.

LHX6 is a sensitive methylation marker in head and neck carcinomas.

Estécio MR, Youssef EM, Rahal P, Fukuyama EE, Góis-Filho JF, Maniglia JV, Goloni-Bertollo EM, Issa JP, Tajara EH.

Oncogene. 2006 Aug 17;25(36):5018-26. Epub 2006 May 29.

PMID:
16732332
9.

Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodeling.

Youssef EM, Issa JP, Lotan R.

Cancer Biol Ther. 2004 Oct;3(10):1002-6. Epub 2004 Oct 2.

PMID:
15467435
10.

Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.

Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R, Issa JP.

Cancer Res. 2004 Apr 1;64(7):2411-7.

11.

Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis.

Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, Hassan K, Feng L, Lee JJ, Lippman SM, Hong WK, Lotan R.

Clin Cancer Res. 2004 Mar 1;10(5):1733-42.

12.

Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer.

Youssef EM, Estecio MR, Issa JP.

Cancer Biol Ther. 2004 Jan;3(1):82-6. Epub 2004 Jan 9.

PMID:
14726683
13.

Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.

Semba S, Itoh N, Ito M, Youssef EM, Harada M, Moriya T, Kimura W, Yamakawa M.

Clin Cancer Res. 2002 Dec;8(12):3824-31.

14.

Human BAC contig covering the deleted region in pancreatic cancer at 12q21.

Youssef EM, Kaneko K, Yatsuoka T, Hayashi Y, Hoshi M, Horii A, Furukawa T.

DNA Seq. 2001;11(6):541-6.

PMID:
11696982
15.

Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.

Feng G, Xu X, Youssef EM, Lotan R.

Cancer Res. 2001 Nov 1;61(21):7999-8004.

17.
18.

An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion.

Semba S, Moriya T, Youssef EM, Sasano H.

Pathol Int. 2000 Jul;50(7):549-52.

PMID:
10886738
19.

Cloning and characterization of the human UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV-homologue (hGnT-IV-H) gene.

Furukawa T, Youssef EM, Yatsuoka T, Yokoyama T, Makino N, Inoue H, Fukushige S, Hoshi M, Hayashi Y, Sunamura M, Horii A.

J Hum Genet. 1999;44(6):397-401.

PMID:
10570912
20.

Elevation of urinary enzyme levels in rat bladder carcinogenesis.

Youssef EM, Wanibuchi H, Mori S, Salim EI, Hayashi S, Fukushima S.

Carcinogenesis. 1999 Jul;20(7):1247-52.

PMID:
10383897
21.

Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer.

Furukawa T, Yatsuoka T, Youssef EM, Abe T, Yokoyama T, Fukushige S, Soeda E, Hoshi M, Hayashi Y, Sunamura M, Kobari M, Horii A.

Cytogenet Cell Genet. 1998;82(3-4):156-9.

PMID:
9858808
22.

Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer.

Kimura M, Furukawa T, Abe T, Yatsuoka T, Youssef EM, Yokoyama T, Ouyang H, Ohnishi Y, Sunamura M, Kobari M, Matsuno S, Horii A.

Cancer Res. 1998 Jun 1;58(11):2456-60.

23.

Overexpression of cyclin D1 in rat esophageal carcinogenesis model.

Youssef EM, Hasuma T, Morishima Y, Takada N, Osugi H, Higashino M, Otani S, Fukushima S.

Jpn J Cancer Res. 1997 Jan;88(1):18-25.

24.

Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.

Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, Watanabe T, Katsura Y, Wanibuchi H, Fukushima S.

Cancer. 1995 Aug 1;76(3):358-66.

PMID:
8625114

Supplemental Content

Loading ...
Support Center